HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui A Sousa Selected Research

alpha-Synuclein

10/2021Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui A Sousa Research Topics

Disease

3Spinal Cord Injuries (Spinal Cord Injury)
01/2023 - 02/2012
2Wounds and Injuries (Trauma)
01/2020 - 04/2012
2Disease Progression
01/2020 - 01/2018
2Neoplasms (Cancer)
01/2018 - 01/2016
1Parkinson Disease (Parkinson's Disease)
10/2021
1Stress Fractures (Stress Fracture)
10/2020
1Acquired Immunodeficiency Syndrome (AIDS)
07/2020

Drug/Important Bio-Agent (IBA)

4HydrogelsIBA
01/2023 - 01/2016
2Biocompatible Materials (Biomaterials)IBA
01/2018 - 01/2016
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2023
1GlycosaminoglycansIBA
01/2023
1alpha-SynucleinIBA
10/2021
1Divalent CationsIBA
07/2020
1glycyl-arginyl-glycyl-aspartyl-serineIBA
01/2020
1Investigational DrugsIBA
01/2018
1Angiogenesis InhibitorsIBA
01/2018
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2018
1IntegrinsIBA
01/2018
1LigandsIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2016
1Fibroins (Fibroin)IBA
01/2016
1ulvanIBA
04/2012
1Polysaccharides (Glycans)IBA
04/2012
1starch polycaprolactoneIBA
02/2012

Therapy/Procedure

1Aftercare (After-Treatment)
10/2020